Trials / Completed

CompletedNCT00642798

An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)

An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects

Status: Completed
Phase: Phase 1
Study type: Interventional
Enrollment: 16 (actual)

Sponsor: Merck Sharp & Dohme LLC · Industry
Sex: All
Age: 18 Years – 45 Years
Healthy volunteers: Accepted

Summary

To support the registration of sitagliptin 100mg in china.

Conditions

Diabetes Mellitus Non-insulin-dependent

Interventions

Type	Name	Description
DRUG	sitagliptin phosphate	Sitagliptin 100mg once daily on Day 1 for single dose, and once daily on Day4-9 for multiple dose.

Timeline

Start date: 2008-03-01
Primary completion: 2008-03-01
Completion: 2008-03-01
First posted: 2008-03-25
Last updated: 2015-02-03

Source: ClinicalTrials.gov record NCT00642798. Inclusion in this directory is not an endorsement.